CASTLE BIOSCIENCES INC
For the period ended Nov 5, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 5, 2026 · Filed Nov 5, 2026
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| NET REVENUES | $102,891 | $83,043 | $290,116 | $257,219 |
| OPERATING EXPENSES | ||||
| Cost of sales (exclusive of amortization of acquired intangible assets) | 23,919 | 18,704 | 68,152 | 52,713 |
| Research and development | 15,807 | 12,960 | 44,778 | 38,335 |
| Selling, general and administrative | 63,792 | 55,907 | 194,813 | 172,592 |
| Amortization of acquired intangible assets | 2,104 | 2,276 | 6,581 | 32,562 |
| Total operating expenses, net | 105,622 | 89,847 | 314,324 | 296,202 |
| Operating loss | (2,731) | (6,804) | (24,208) | (38,983) |
| Interest income | 2,512 | 2,833 | 7,413 | 8,876 |
| Net (losses) gains on equity securities | (3,425) | 3,561 | (2,033) | 3,321 |
| Interest expense | (197) | (24) | (524) | (62) |
| Other income (expense) | 39 | 48 | (553) | 48 |
| Loss before income taxes | (3,802) | (386) | (19,905) | (26,800) |
| Income tax expense (benefit) | 298 | 115 | 777 | (4,974) |
| Net loss | $(4,100) | $(501) | $(20,682) | $(21,826) |
| Loss per share: | ||||
| Basic | $(0.13) | $(0.02) | $(0.69) | $(0.76) |
| Diluted | $(0.13) | $(0.02) | $(0.69) | $(0.76) |
| Weighted-average shares outstanding: | ||||
| Basic | 30,633 | 29,073 | 30,112 | 28,868 |
| Diluted | 30,633 | 29,073 | 30,112 | 28,868 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.